Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions-Reference-Cited by-同舟云学术

Treatment for carbapenem-resistant Enterobacterales infections: recent advances and future directions

Published:2021-06-24 Issue:10 Volume:40 Page:2053-2068
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

Tompkins Kathleen^ORCID,van Duin David

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10096-021-04296-1.pdf

Reference234 articles.

1. The World Health Organization . Antibiotic resistance. https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance. Accessed 25 Feb 2021

2. United States Centers for Disease Control and Prevention. Clinicians: Information about CRE. https://www.cdc.gov/hai/organisms/cre/cre-clinicians.html (2019). Accessed 25 Feb 2021

3. Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA (2011) Carbapenems: past, present, and future. Antimicrob Agents Chemother 55:4943–4960

4. van Duin D, Doi Y (2017) The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence 8:460–469

5. Nordmann P, Poirel L (2014) The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin Microbiol Infect 20:821–830

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unleashing the power of polymeric nanoparticles — Creative triumph against antibiotic resistance: A review;International Journal of Biological Macromolecules;2024-10

2. Isolation and characterization of a multidrug-resistant carbapenem-resistant Klebsiella pneumoniae strain co-carrying IncFII/IncR-KPC-2 and phage-like plasmids;Gene Reports;2024-09

3. A molecular analysis of meropenem–vaborbactam non-susceptible KPC-producing Klebsiella pneumoniae;Antimicrobial Agents and Chemotherapy;2024-08-20

4. Phenotypic and molecular characterization of multidrug-resistant Enterobacterales isolated from clinical samples in Palestine: a focus on extended-spectrum β-lactamase- and carbapenemase-producing isolates;BMC Infectious Diseases;2024-08-12

5. Synergistic Activity of Cefiderocol in Combination with Avibactam, Sulbactam or Tazobactam against Carbapenem-Resistant Gram-Negative Bacteria;Cells;2024-08-06